investors

Novo Nordisk’s next-gen obesity drug results a letdown for investors

CHICAGO — Late-stage results of Novo Nordisk’s obesity candidate CagriSema suggest the drug is comparable to Eli Lilly’s Zepbound on safety and efficacy, further data indicating that CagriSema may not be the standout treatment that investors had hoped for. Novo previously reported that patients on CagriSema lost 20% of their weight in a 68-week Phase … [Read more…]

CHIHUO, North America’s largest Asian restaurants discovery platform, to kick off fourth annual summit “2023 Taste of Asia” with world-class food connoisseurs and investors

The largest Asian food and beverage industry conference in North America, “2023 Taste of Asia,” backed by renowned restaurants discovery platform and incubator CHIHUO, is returning to San Jose, California, for the fourth year in a row on August 27th. CHIHUO, literally meaning “food squad” in Chinese, was launched by former international student Amy Duan … [Read more…]